Physician profile
David Paul Johnson
NPI 1053601229
$23,408.84
in general payments reported to CMS, 2019-2025
21 companies · $18K in 2025
The $18K reported for 2025 was more than what 92% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,680 · 2020: $109 · 2021: $795 · 2022: $656 · 2023: $746 · 2024: $1,190 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $12K · Consulting Fee: $5,350 · Food and Beverage: $3,181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $11,638.18 |
| Consulting Fee | $5,350.00 |
| Food and Beverage | $3,180.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $15,474.98 | 2020-2025 | Artis Icono Floor |
| Terumo Medical Corporation | $2,658.34 | 2019-2025 | Angio-Seal, Azur Cx Detachable, Progreat |
| Penumbra, INC. | $2,067.44 | 2019-2025 | Indigo System, Penumbra System, Ruby Coil |
| Inari Medical, INC. | $686.36 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $493.91 | 2022-2025 | Osteocool Rf Ablation System, Concerto Versa, Concertotm |
| Boston Scientific Corporation | $487.69 | 2020-2025 | Icefx Cryoablation System, Cryoablation Needles |
| Sirtex Medical INC | $376.49 | 2019-2025 | Lava Les (Liquid Embolic System), Sir-Spheres Microspheres |
| Astrazeneca Pharmaceuticals LP | $209.68 | 2019 | |
| Angiodynamics, INC. | $193.82 | 2021 | |
| Trisalus Life Sciences, INC. | $144.26 | 2023-2025 | Trinav Infusion System |
| Stryker Corporation | $142.31 | 2022 | |
| Acell, INC. | $94.47 | 2019 | |
| Ethicon US, LLC | $83.53 | 2021 | |
| W. L. Gore & Associates, INC. | $79.34 | 2023-2024 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis |
| Mozarc Medical US LLC | $65.37 | 2023-2025 | Argyle, Palindrome, Chameleon |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $59.01 | 2019-2022 | |
| Merit Medical Systems INC | $23.57 | 2020-2023 | Stabilit |
| Bard Peripheral Vascular, INC. | $17.65 | 2021 | |
| Merck Sharp & Dohme LLC | $17.38 | 2021 | |
| Cordis US Corp. | $16.69 | 2024 | Mynx Venous Vcd |
| Ibsa Pharma INC. | $16.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.